Opinion
‘Failing’ Government Report Into Medicinal Cannabis Is A ‘Missed Opportunity’
The Advisory Council for the Misuse of Drugs’ recent report on cannabis medicines is a missed opportunity, says Pierre Van Weperen of The Grow Group AS a leading distributor of unlicensed CBMPs in the UK, Grow Pharma welcomes research commissioned by the government into this very exciting and rapidly growing area.
